P477: Assessment of treatment sequence and real-world outcomes in patients with Ulcerative ColitisECCO'21 VirtualYear: 2021
Authors: Chen, J.(1);Zhao, Y.(1);Liu, T.(1);Candela, N.(2);Lasch, K.(2);
(1)Takeda Development Center Americas Inc., Biostatistics, Cambridge, United States;(2)Takeda Pharmaceuticals USA Inc., US Medical, Lexington, United States
P478: Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard-dose subcutaneous maintenance therapy: an observational multicentre studyECCO'21 VirtualYear: 2021
Authors: Olmedo-Martín, R.(1);Martín-Rodríguez, M.D.M.(2);Lorenzo-González, L.(3);Lázaro-Sáez, M.(4);Lopez-Vico, M.(2);Hernández-Martínez, Á.(5);Argüelles-Arias, F.(3);Vázquez-Morón, J.M.(6);
(1)Hospital Regional Universitario, Servicio de Aparato Digestivo, Málaga, Spain;(2)Hospital Universitario Virgen de las Nieves, Servicio de Aparato Digestivo, Granada, Spain;(3)Hospital Universitario Virgen Macarena, Servicio de Aparato Digestivo, Sevilla, Spain;(4)Hospital Universitario Torrecárdenas, Servicio de Aparato Digestivo, Almería, Spain;(5)Hospital Universitario Torrecárdenas, Servicio de Aparato Digestivo, Almería, Spain;(6)Hospital Universitario Juan Ramón Jiménez, Servicio de Aparato Digestivo, Huelva, Spain; GATEII (Grupo Andaluz de Trabajo en Enfermedad Inflamatoria Intestinal)
P479: Biological therapies and bio-microbial dynamics in inflammatory bowel diseasesECCO'21 VirtualYear: 2021
Authors: Tavakoli, P.(1);Vollmer-Conna, U.(2);Hadzi-Pavlovic, D.(2);Grimm, M.C.(3);Vázquez-Campos, X.(4);
(1)University of New South Wales, Faculty of Medicine-St George and Sutherland Clinical School, Sydney, Australia;(2)University of New South Wales, School of Psychiatry, Sydney, Australia;(3)University of New South Wales, St George and Sutherland Clinical School, Sydney, Australia;(4)University of New South Wales, School of Biotechnology and Biomolecular Sciences, Sydney, Australia
P481: Effectiveness and safety profile of biological therapy in inflammatory bowel disease: real life data from an active pharmacovigilance projectECCO'21 VirtualYear: 2021
Authors: Viola, A.(1);Barbieri , M.A.(2);Pisana, V.(1);Cutroneo , P.M.(3);Fries, W.(1);Spina, E.(2);
(1)University of Messina, IBD-unit- Dept. of Clinical and Experimental Medicine, Messina, Italy;(2)University of Messina, Dept. of Clinical and Experimental Medicine, Messina, Italy;(3)AOU Policlinico G. Martino, Sicilian Regional Pharmacovigilance Center, Messina, Italy
P482: Safety and efficacy of ustekinumab for Crohn’s disease in the elderly populationECCO'21 VirtualYear: 2021
Authors: Fiske, J.(1);Liu, E.(2);Limdi, J.(2);Conley, T.E.(1);Townsend, T.(1);Davies, M.(3);Brockwell, R.(3);Baig, D.(1);Abdelbadiee, S.(1);Uney, A.(1);Liaros, A.(4);Gaba, W.(5);Smith, P.J.(1);Subramanian, S.(1);
(1)Liverpool University Hospitals NHS Foundation Trust, Gastroenterology, Liverpool, United Kingdom;(2)Pennine Acute Hospitals NHS Trust, Gastroenterology, Manchester, United Kingdom;(3)Arrowe Park Hospital, Gastroenterology, Wirral, United Kingdom;(4)Whiston Hospital, Gastroenterology, Whiston, United Kingdom;(5)Warrington Hospital, Gastroenterology, Warrington, United Kingdom
P484: Remote monitoring allows an individualized approach and showed excellent usability at the infusion unitECCO'21 VirtualYear: 2021
Authors: Fierens, L.(1);Geens, P.(2);De Dycker, E.(2);Paps, A.(2);Lambrechts, T.(2);Sabino, J.(1,2);Vermeire, S.(1,2);Ferrante, M.(1,2);
(1)Catholic University of Leuven, Department of Chronic Diseases- Metabolism and Ageing, Leuven, Belgium;(2)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium; Leuven IBD Group
P485: Development and implementation of a remote monitoring tool for real-world assessment of mild, moderate and severe infectious complications in Inflammatory Bowel Disease patientsECCO'21 VirtualYear: 2021
Authors: Rezazadeh Ardabili, A.(1,2);Wintjens, D.S.J.(1,2);Mujagic, Z.(1,2);Cilissen, M.(1);Stassen, L.P.S.(3);Haans, J.J.L.(1);Jonkers, D.M.A.E.(1,2);Pierik, M.J.(1,2);
(1)Department of Internal Medicine- Division of Gastroenterology and Hepatology, Maastricht University Medical Centre+, Maastricht, The Netherlands;(2)School for Nutrition and Translational Research in Metabolism NUTRIM, Maastricht University Medical Centre+, Maastricht, The Netherlands;(3)Department of Surgery, Maastricht University Medical Centre+, Maastricht, The Netherlands
P487: The feasibility of a digital platform for improving disease management among patients with Ulcerative ColitisECCO'21 VirtualYear: 2021
Authors: Oddsson, S.(1);Gunnarsdottir, T.(1);Ylanne, K.(2);Molander, P.(3);Thorgeirsson, T.(1);
(1)Sidekick Health, Medical and Research, Kopavogur, Iceland;(2)Sidekick Health, Customer Success, Kopavogur, Iceland;(3)Helsinki University Hospital- Helsinki University, Abdominal Center- Gastroenterology, Helsinki, Finland
P488: The COVID19 pandemic impact on Inflammatory Bowel Disease Patients Management in a Romanian Tertiary Gastroenterology CentreECCO'21 VirtualYear: 2021
Authors: Costache, R.(1);Iacob, R.(1);Vadan, R.(1);Stroie, T.(1);Gheorghe, L.(1);Diculescu, M.(1);Gheorghe, C.(1);
(1)Clinical Institute Fundeni, Gastroenterology and Hepatology, Bucharest, Romania
P489: Rescue treatment with original versus biosimilar infliximab in biologic-naïve patients with moderate-severe Ulcerative Colitis and corticosteroid failureECCO'21 VirtualYear: 2021
Authors: Muñoz-Villafranca, C.(1);Ogueta, M.Á.(2);Ramírez de la Piscina, P.(2);Álvarez-Herrero, B.(2);Loizate, A.(3);Gómez-Zabala, J.M.(3);De La Maza-Ortiz, S.(1);Aresti, U.(4);Gorostiza, I.(4);Arreba, P.(1);Irigoyen, M.(5);Ortiz de Zárate, J.(1);
(1)Hospital Universitario de Basurto, Gastroenterology Department, Bilbao, Spain;(2)Hospital Universitario Araba, Gastroenterology Department, Vitoria, Spain;(3)Hospital Universitario Basurto, Surgery Department, Bilbao, Spain;(4)Hospital Universitario Basurto, Investigation Department, Bilbao, Spain;(5)Hospital Universitario Príncipe de Asturias, Internal Medicine Department, Alcalá de Henares, Spain
P490: The impact of the COVID-19 pandemic on gastroenterologists providing care to inflammatory bowel disease patients in Canada: preliminary data of a cross-sectional surveyECCO'21 VirtualYear: 2021
Authors: Mikail, M.(1);Malhi, G.(1);Wilson, A.(2);Khanna, R.(3);
(1)Western University, Schulich School of Medicine & Dentistry - Department of Medicine, London, Canada;(2)Western University, Schulich School of Medicine & Dentistry - Department of Gastroenterology- Division of Clinical Pharmacology and Department of Physiology & Pharmacology, London, Canada;(3)Western University, Schulich School of Medicine & Dentistry - Department of Gastroenterology, London, Canada
P491: Infectious risk of vedolizumab compared with other biological agents in the treatment of Inflammatory Bowel DiseaseECCO'21 VirtualYear: 2021
Authors: Innocenti, T.(1,2);Roselli, J.(1,2);Lynch, E.N.(1,2);Apolito, P.(1,2);Parisio, L.(1,2);Bagnoli, S.(2);Macrì, G.(2);Rogai, F.(2);Milani, S.(1);Galli, A.(1);Milla, M.(2);Dragoni, G.(1,2,3);
(1)University of Florence, Department of Experimental and Clinical Biomedical Sciences 'Mario Serio”, Florence, Italy;(2)Azienda Ospedaliero Universitaria Careggi, IBD Referral Centre, Florence, Italy;(3)University of Siena, Department of Medical Biotechnologies, Siena, Italy
P492: The UC Diet and Antibiotics for Treatment of Mild to Moderate Pediatric Ulcerative Colitis: A prospective open label pilot studyECCO'21 VirtualYear: 2021
Authors: Sarbagili Shabat, C.(1,2);Albenberg, L.(3);Van Limbergen, J.(4,5);Otley, A.(6);Yaakov, M.(1);Wine, E.(7);Weiner, D.(1);Levine, A.(1,2);
(1)Edith Wolfson Medical Center, PIBD Research center- Paediatric Gastroenterology and Nutrition Unit, Holon, Israel;(2)Tel-Aviv University, The Sackler Faculty of Medicine, Tel-Aviv, Israel;(3)Children’s Hospital of Philadelphia, Division of Gastroenterology- Hepatology- and Nutrition, Philadelphia- Pennsylvania, United States;(4)Amsterdam University Medical Centers, Emma Children’s Hospital, Amsterdam, The Netherlands;(5)University of Amsterdam, Tytgat Institute for Liver and Intestinal Research- Amsterdam Gastroenterology and Metabolism- Academic Medical Center, Amsterdam, The Netherlands;(6)IWK Health Center, Division of Gastroenterology and Nutrition, Halifax, Canada;(7)University of Alberta, Departments of Pediatrics and Physiology, Edmonton- Alberta, Canada
P493: Cost-effectiveness of venous thromboembolism prophylaxis after hospitalization in patients with Inflammatory Bowel DiseaseECCO'21 VirtualYear: 2021
Authors: Lee, K.(1);Lim, F.(2);Colombel, J.F.(3);Hur, C.(2);Faye, A.(3);
(1)Columbia University Vagelos College of Physicians and Surgeons, Medicine- Division of Digestive and Liver Diseases, New York, United States;(2)Columbia University Irving Medical Center, Medicine- Division of Digestive and Liver Diseases, New York, United States;(3)Icahn School of Medicine at Mt. Sinai, The Dr. Henry D. Janowitz Division of Gastroenterology, New York, United States
P494: Can Patients Monitor Response To Ustekinumab In The Real World?ECCO'21 VirtualYear: 2021
Authors: Walsh, A.J.(1);Matini, L.(1);Kormilitzin, A.(2);Wilson, J.(1);Lyden, S.(1);Al-Hillawi, L.(1);Kantschuster, R.(1);White, L.(1);Payton, S.(1);Brain, O.(1);Palmer, R.(1);Ambrose, T.(1);Satsangi, J.(1);Travis, S.P.L.(1);
(1)Oxford University Hospitals NHS Foundation Trust, Translational Gastroenterology Unit, Oxford, United Kingdom;(2)University of Oxford, Mathematical Institute, Oxford, United Kingdom
P495: The interplay of biopsychosocial factors and quality of life in Inflammatory Bowel Diseases: a network analysisECCO'21 VirtualYear: 2021
Authors: Knödler, L.L.(1);Thomann, A.(1);Karthikeyan, S.(2);Atanasova, K.(3);Bernstein, C.(4);Ebert, M.(1);Lis, S.(3);Reindl, W.(1);
(1)University Medical Center Mannheim- Medical Faculty Mannheim- Heidelberg University, Department of Medicine II, Mannheim, Germany;(2)Institute of Psychiatric and Psychosomatic Psychotherapy- Medical Faculty Mannheim- Heidelberg University- Central Institute of Mental Health- Mannheim- Germany, Experimental Psychology, , Germany;(3)Institute of Psychiatric and Psychosomatic Psychotherapy- Medical Faculty Mannheim- Heidelberg University- Central Institute of Mental Health- Mannheim- Germany, Experimental Psychology, Mannheim, Germany;(4)Faculty of Medicine- University of Manitoba- Winnipeg- MP- Canada, Department of Gastroenterology, Winnipeg, Canada
P496: Efficacy and safety of elective switching of inflammatory bowel disease patients from intravenous to subcutaneous infliximab (IFX): a multi-centre cohort studyECCO'21 VirtualYear: 2021
Authors: Smith, P.J.(1);Storey, D.(1);Gregg, B.(1);Critchley, L.(1);Stenson, J.(1);Kneebone, A.(1);Rimmer, T.(1);Burke, S.(1);Hussain, S.(2);Teoh, W.Y.(2);Vazeille, S.(2);Serna, S.(3);Bond, A.(1);Steel, A.(1);Dibb, M.(1);Collins, P.(1);Derbyshire, E.(1);Bodger, K.(1);Probert, C.(1);Verma, A.(3);Subramanian, S.(1);
(1)Department of Gastroenterology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom;(2)Liverpool School of Medicine, University of Liverpool, Liverpool, United Kingdom;(3)Department of Gastroenterology, Kettering General Hospital, Kettering, United Kingdom